 A patch containing oxybutynin Oxytrol for controlling overactive bladder may be sold overthecounter for women  and older the FDA said Friday Men will continue to need a prescription for the drug the agency said The OTC product will be marketed by Merck as Oxytrol for Women Oxybutynin is an anticholinergic agent that acts as a bladder muscle relaxant No agent in this class has been available overthecounter before according to the FDA The approval comes despite an agency   the OTC switch in November Panel members expressed concerns about inappropriate use of the drug without a physicians oversight or diagnosis of overactive bladder As one said during the November meeting I dont think that we have shown that patients can appropriately selfselect Approval of the OTC formulation was supported by nine studies in more than  patients Overall results from these studies showed that consumers can understand the information on the label properly select whether the product is right for them and use the drug appropriately the FDA said Adverse effects seen in these studies included mild skin irritation at the patch site dry mouth and constipation Mercks studies also found that men were relatively poor at correctly determining whether oxybutynin was the appropriate treatment for their urination problems A key worry is that incorrect selfdiagnosis in men could delay detection of prostate cancer Consequently the company did not seek OTC status for the product in men Source 